Citations

Clear

396 citation(s) found for "Spinner, M".

Cognitive (Over)load in Oncology Education: Using Principles of Learning Theory and Artificial Intelligence for a Sustainable Future
Augustin, Ryan C , Wolanskyj-Spinner, Alexandra P , Comfere, Nneka I.

Mayo Clinic

American Society of Clinical Oncology Educational Book | November 10, 2026 | Volume: 46 | Issue: 4 | Pages: No page available

10.1200/edbk-26-00003 | PMID 43008248 Get It

Targeting NF-κB prevents Schwann cell reprogramming and plexiform neurofibroma initiation in mouse model of Nf1
Ravindran, Ramya , Youn, Eui-Kyung, Kedei, Noémi , Choi, Kwangmin , Volz, Avery, Dombi, Eva , Pundavela, Jay , Kim, MiOk, Spinner, Robert J. , Szabo, Sara , Largaespada, David A. , Shern, Jack F. , Ratner, Nancy

Mayo Clinic

No container title available | November 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.11.04.764357 Get It

Plexiform neurofibromas arise in approximately half of all individuals with Neurofibromatosis Type I (NF1). Genetic lesions apart from NF1 pathogenic variants are not present in NF1 mutant Schwann cells, suggesting that tumorigenesis may instead require cellular rewiring. To identify putatively re-wired tumor cells, we used multiplex imaging and flow cytometry to delineate markers that distinguish tumor Schwann cell from non-tumor Schwann cells. We identified tumor Schwann cells as CD44+;CD49f+ cells that show increased transcription of epithelial to mesenchymal plasticity (EMP)- associated genes. CD44+;CD49f+ expression was induced by treating Nf1-/- Schwann cells with stressors or by direct NF-κB pathway activation via IKK2; treated Schwann cells increased secretion of NF-κB targets and immune cell chemoattractants CCL2 and CCL3. In established tumors, MEK inhibition plus NF-κB blockade diminished tumor cell proliferation, tumor Schwann cells, immune cell populations, tumor cytokines and tumor number. Notably, transient single agent NF-κB pathway blockade was sufficient to significantly delay tumor formation in mice. Thus, Nf1 loss in Schwann cells is followed by NF-κB activation and cellular reprogramming that drives tumor initiation and targeting NF-κB activation can reduce NF1-deficient tumor formation.
FDG PET characteristics of intraneural perineurioma: patient series
Amrami, Abigail B., Marek, Tomáš , Spinner, Robert J. , Broski, S. M., Amrami, Abigail, Broski, Stephen M.

Mayo Clinic

Journal of Neurosurgery: Case Lessons | September 23, 2026 | Volume: 12 | Issue: 13 | Pages: No page available

10.3171/case26698 | PMID 42804796 Get It

BACKGROUND Intraneural perineuriomas (INPs) are rare benign peripheral nerve sheath tumors with characteristic clinical and MRI features. Their 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) appearance has not been characterized in a patient series. The authors evaluated FDG uptake patterns in INP. OBSERVATIONS The authors retrospectively reviewed that data of patients with confirmed INP who had MRI and FDG PET studies that included the affected nerve. Eight patients were included (5 male and 3 female; mean age 30.8 years, range 16–61 years). All lesions showed mildly increased FDG uptake relative to the contralateral nerve (lesion maximum standardized uptake value [SUVmax]: mean 1.5, median 1.2, range 1.1–3.5; contralateral nerve SUVmax: mean 0.9, median 0.9, range 0.8–1.0) and skeletal muscle background (SUVmean: mean 0.8, range 0.5–0.9). Six patients had denervation edema and/or fatty atrophy, without appreciably increased FDG uptake in the affected musculature. No additional abnormal hypermetabolic foci were identified. LESSONS INPs generally demonstrate low-level FDG uptake. PET is best regarded as a complementary test when already available or when metabolic characterization may refine the differential diagnosis; unexpectedly high uptake should prompt reconsideration of the diagnosis or additional evaluation. https://thejns.org/doi/10.3171/CASE26698
Second Line CD19 CAR-T vs Platinum Salvage and Autologous Stem Cell Transplant for Primary Mediastinal B-Cell Lymphoma
Dumke, Henry , Thiruvengadam, Swetha Kambhampati, Argao, Christine, Schroers‐Martin, Joseph G. , Lanka, Sree M , Sawalha, Yazeed , Alharthy, Hanan , Ahmed, Sairah , Okcu, Izel, Nowakowski, Grzegorz S. , Doukas, Peter , Shanmugasundaram, Krithika , Colton, Meryl, Spinner, Michael A. , Rodriguez, Stefania M. , Lakin, Brock G., D’Angelo, Christopher R., Kamdar, Manali, Adewale, Olutobi, Baron, Margaret Kelsey , Bock, Allison M. , Geer, Marcus , Karimi, Yasmin , Dumke, Henry , Schroers-Martin, Joseph G , Lanka, Sree , Sawalha, Yazeed , Alharthy, Hanan , Ahmed, Sairah , Doukas, Peter G , Karmali, Reem , Shanmugasundaram, Krithika , Duvall, Adam , Pizzuti, Vincenzo J , Adewale, Olutobi , Rhodes, Joanna , Tiger, Yun Kyoung Ryu, Baron, Kelsey , Bock, Allison M , Geer, Marcus J , Karimi, Yasmin H , Yang, Xi , Thiruvengadam, Swetha Kambhampati, Karmali, Reem , Colton, Meryl D. , DuVall, Adam , D’Angelo, Christopher R. , Pizzuti, Vincenzo J. , Kamdar, Manali , Rhodes, Joanna , Tiger, Yun Kyoung

Mayo Clinic

Blood Advances | August 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1182/bloodadvances.2026020965 | PMID 42623675 Get It

Primary mediastinal B-cell lymphoma (PMBCL) is a rare form of large B-cell lymphoma (LBCL) with around 90% of patients cured with frontline treatment. For relapsed or refractory (R/R) disease, the optimal treatment is unclear. CD19 chimeric antigen receptor-T cell (CAR-T) has been established as the preferred second line (2L) treatment for primary refractory or early relapsing LBCL based on the overall survival benefits observed in the landmark phase III trials. However, PMBCL patients were underrepresented on these pivotal studies. This study evaluated outcomes of 252 patients treated with 2L therapies for R/R PMBCL at 14 US institutions between 2001 and 2025. Platinum-based salvage with intent to proceed to high dose therapy and autologous stem cell transplant (HDT/ASCT) (platinum cohort) and CD19 CAR-T (CAR-T cohort) were given as 2L therapy in the real-world setting in 157 and 26 patients, respectively. Overall response rate (ORR), complete response (CR) rate and median progression-free survival (PFS) were significantly higher in the CAR-T cohort compared with the platinum cohort (ORR: 91.3% vs 44.2%, p <0.001; CR 65.2% vs 14.7%, p<0.001; median PFS not reached vs 3.5 months, hazard ratio (HR) 0.28, 95% CI 0.15-0.54, p=0.001). No significant difference was observed in overall survival. This study demonstrated superior response rate and PFS of CD19 CAR-T over platinum-based salvage with intent to proceed to HDT/ASCT as 2L treatment for R/R PMBCL.
A comprehensive analysis of ganglioneuromas: a 30-year experience of 101 patients
Texakalidis, Pavlos , Gogoi, Rahul , Spinner, Robert J., Spinner, Robert J.

Mayo Clinic

Journal of Neurosurgery | July 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-7

10.3171/2026.2.jns252992 | PMID 42537227 Get It

OBJECTIVE Ganglioneuromas (GNs) are rare benign tumors arising from sympathetic neural crest derivatives, with limited large-scale data guiding management. The objective of this study was to characterize the clinical presentation, imaging features, surgical management, and long-term outcomes of patients with GN treated at a single institution over a 30-year period. METHODS The authors conducted a retrospective review of all patients diagnosed with GN between 1995 and 2025 at a single institution. Clinical data, imaging characteristics, operative details, perioperative complications, and long-term outcomes were abstracted. RESULTS A total of 101 patients (62.3% female, mean age 26.9 ± 15.9 years) were identified. Tumors most commonly arose in the retroperitoneum (n = 46, 45.5%), thoracic paraspinal/mediastinal region (n = 33, 32.7%), presacral space (n = 18, 17.8%), and cervical region (n = 4, 4%). The mean tumor dimensions on MRI were 8.5 ± 3.8 × 6.6 ± 3.2 × 5.8 ± 3.7 cm. Most lesions (72%) were incidental findings. Seventy patients underwent 72 surgeries, of which 69.4% had preoperative biopsy confirmation. Gross-total resection (GTR) was achieved in 73.6% of cases (53/72) and subtotal resection (STR) was performed in 26.4% (19/72). Short-term postoperative complications occurred in 43.1% of cases, most commonly neurological deficits (22.2%). The mean hospital length of stay was 4.6 ± 3.7 days. At the final follow-up (mean duration 33.8 ± 42.6 months), 46.5% of patients were stable, 42.3% had improved, and 11.3% had worsened from baseline. Two patients experienced recurrence (2.9%, 2/70). No malignant transformations were observed. Thirty-one patients were managed with observation (mean age 32.3 ± 17.7 years; mean follow-up duration 90.9 ± 151 months). Observation was chosen primarily due to proximity to major vascular or neural structures (74.2%). No patient in the observation group developed new symptoms, and 2 tumors exhibited minimal interval growth (0.08–0.17 cm/year). CONCLUSIONS GNs demonstrate indolent behavior, low recurrence rates, and no observed malignant transformation in this large cohort. GTR is achievable in most cases, but STR provides excellent long-term control when required to avoid morbidity. Observation is safe for asymptomatic tumors, particularly when adjacent to critical structures, with no growth observed on long-term follow-up, except for minimal growth in few cases. These findings support an individualized, risk-based approach to management.
Diagnosing metastatic angiosarcoma arising from MPNST using H3K27me3 staining in NF1: illustrative case
Hagan, M Teresa, Spinner, Robert J. , Torres‐Mora, Jorge , Hagan, Michael K A

Mayo Clinic

Journal of Neurosurgery: Case Lessons | July 22, 2026 | Volume: 12 | Issue: 3 | Pages: No page available

10.3171/case251012 | PMID 42475741 Get It

BACKGROUND Malignant peripheral nerve sheath tumors (MPNSTs) are malignant tumors that rarely demonstrate heterologous differentiation from angiosarcomatous components. These lesions can be hard to accurately diagnose. OBSERVATIONS A 25-year-old man with neurofibromatosis type 1 and a history of a left lumbar subcutaneous MPNST developed a lung metastasis of only the angiosarcoma component of the MPNST. Prior to H3K27me3 staining of the lung mass, there was no association of the angiosarcoma with the MPNST. Reinterpretation of the lumbar subcutaneous MPNST led to the identification of a previously unrecognized angiosarcomatous portion in that tumor as well. LESSONS This case highlights the importance of using H327me3 staining for accurate diagnosis of biopsies only capturing the heterologous components of MPNST. https://thejns.org/doi/10.3171/CASE251012
A novel microvascular arterio-neural pathway for intraneural ganglion cyst formation secondary to cystic adventitial disease: illustrative case
Piyawattanametha, Nontaphon , Ruiter, Godard C. W. de , Reina, Miguel Ángel , Amrami, Kimberly K. , Kalra, Manju, Spinner, Robert J. , Reina, Miguel Angel , Spinner, Robert J , Marek, Tomáš , Kalra, Manju

Mayo Clinic

Journal of Neurosurgery: Case Lessons | July 22, 2026 | Volume: 12 | Issue: 3 | Pages: No page available

10.3171/case26411 | PMID 42475738 Get It

BACKGROUND Cystic adventitial disease (CAD) and intraneural ganglion cysts (IGCs) are rare mucinous lesions typically linked to an articular origin via macroscopic conduits. While secondary propagation between vascular and neural systems may occur through shared fascial sheaths, a direct microvascular route has not been previously described. OBSERVATIONS A 60-year-old man presented with progressive left tibial neuropathy. High-resolution 7T MRI and surgery revealed a large popliteal CAD lesion connecting to the knee joint via the middle genicular artery, alongside a secondary tibial IGC lacking an independent articular nerve connection. Findings demonstrated that high-pressure CAD mucin tracked along a small connecting vascular branch, creating a novel microvascular arterio-neural pathway to infiltrate the tibial nerve. Targeted articular branch disconnection and cyst decompression yielded significant clinical improvement, with no recurrence on 7-month follow-up 7T MRI. LESSONS This case expands the unifying articular theory, demonstrating that synovial fluid propagation can exploit a microvascular arterio-neural pathway rather than strictly macroscopic fascial planes. High-resolution 7T MRI is essential for visualizing these subtle connections. Successful management requires meticulous identification and disconnection of the primary joint connection to prevent recurrence. https://thejns.org/doi/10.3171/CASE26411
Surgical treatment of schwannomas around the tarsal tunnel: a case series of 40 patients and systematic review of the literature
Ruiter, Godard C. W. de , Hayford, Kirsten M., Vissers, Thomas , Spinner, R, Spinner, Robert J.

Mayo Clinic

Journal of Neurosurgery | July 1, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-13

10.3171/2026.1.jns252605 | PMID 42398116 Get It

OBJECTIVE Schwannomas in the tibial, plantar, or medial calcaneal nerves around the ankle can mimic symptoms of tarsal tunnel syndrome. Outcomes after resection of schwannomas from these nerves have mainly been reported in case reports. The objectives of this study were to investigate the presentation and results for resection of schwannomas around the tarsal tunnel in a large case series and systematically review the currently available literature. METHODS Data from 40 patients (27 sporadic and 13 schwannomatosis cases) treated at 2 centers were retrospectively analyzed for preoperative type and duration of symptoms, schwannoma size at presentation, and outcome after resection. The following different locations around the ankle were compared: proximal to the tarsal tunnel (PTT), at the tarsal tunnel (ATT), and distal to the tarsal tunnel (DTT). The severity of symptoms was categorized in increasing order for pain only on touch, during load-bearing activities, and symptoms also at rest. Surgical outcome was assessed based on pain relief and occurrence of complications. The systematic literature review was performed using a PubMed and Embase search. RESULTS All but 1 patient presented with pain, local at the ankle, or neuropathic pain during weight-bearing activities (13/40, 32.5%). More than half of the patients also experienced symptoms at rest (52.5%). In 14 cases, the schwannoma was located PTT, in 17 cases ATT, and in 9 cases DTT in the plantar nerves. There were no significant differences in size and symptom duration at presentation for the different locations. Tumor size did not correlate with symptom severity. Outcomes after resection were excellent, with complete pain relief in all but 1 patient (97.0%). Complications included wound infection (5%) and temporary decreased sensation on the heel (7.5%). A review of 44 previously reported cases also frequently showed complete pain relief after resection. CONCLUSIONS The results of this study show that schwannomas around the tarsal tunnel often present with severe pain symptoms, even if the lesion is still relatively small. Resection frequently results in excellent pain relief. During surgery, it may not be necessary to open the entire length of the tarsal tunnel, thereby limiting the size of the incision, especially in schwannomas located proximally or distally to the tarsal tunnel.
Fluorescein-Guided Surgery for Medial Plantar Nerve Intraneural Ganglion Cysts: 2-Dimensional Operative Video
Gogoi, Rahul , Spinner, Robert J. , Texakalidis, Pavlos , Ruiter, Godard C. W. de, Ruiter, Godard C. W. de

Mayo Clinic

Operative Neurosurgery | June 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/ons.0000000000002112 | PMID 42318893 Get It